FDA Accepts Zydus Biosimilar Application for Review
The US Food and Drug Administration accepted Zydus Lifesciences' application to review its proposed biosimilar to Keytruda (pembrolizumab), according to the report.
Related stories
US Approve Patriot Missile Sale to Ukraine
The United States approved the sale of Patriot missiles to Ukraine.
M impact | REGULATION | Oct 30, 2026, 07:42 PM UTC
Mexico Finance Minister Says Deficit Likely to Reach 4.1% of GDP Target
Mexico's finance minister said the September deficit was 2.6% of GDP and is likely to reach the 4.1% target.
M impact | REGULATION | Oct 30, 2026, 07:23 PM UTC
US Approves Possible $2.1 Billion Patriot Missile Sale to Ukraine
The US State Department approved a possible $2.1 billion Patriot missile sale to Ukraine.
M impact | REGULATION | Oct 30, 2026, 07:01 PM UTC
US Sanctions Former Police Chief Accused of War Crimes by ICC
The United States sanctioned a former police chief accused of war crimes by the International Criminal Court.
M impact | REGULATION | Oct 30, 2026, 06:35 PM UTC
US reportedly extends sanctions relief for Serbia’s NIS through Dec. 11
Reuters reports that the United States extended the Serbian oil company NIS’s exemption from sanctions through Dec. 11.
M impact | REGULATION | Oct 30, 2026, 05:59 PM UTC
US SEC Enforcement Director: Agency is examining AI company disclosures. Wants to ensure companies are giving investors a full picture of the risks as AI spending booms.
L impact | REGULATION | Oct 30, 2026, 05:49 PM UTC